Arterial interventional chemotherapy and IMRT with concurrent chemotherapy for nasopharyngeal carcinoma with intracranial involvement

Qiu C, Yang N, Tian G, et al: Weight loss during radiotherapy for nasopharyngeal carcinoma: a prospective study from northern China. Nutr Cancer. 63:873–879. 2011. View Article : Google Scholar : PubMed/NCBI

Yi JL, Gao L, Huang XD, et al: Nasopharyngeal cancinoma treated by radical radiotherapy alone: Ten-year experience of a single institution. Int J Radial Oncol Biol Phys. 65:161–168. 2006.PubMed/NCBI

Lu T, Zhao C, Wu SX, et al: Retrospective analysis of 934 primary nasopharyngeal cancinoma (NPC) patients treated with conventional external-beam radiotherapy alone. Zhonghua Zhong Liu Za Zhi. 60(suppl): 508–509. 2004.(In Chinese).

Al-Sarraf M, Le Blanc M, Giri PG, et al: Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer. Phase III randomized intergroup study 0099. J Clin Oncol. 16:1310–1317. 1998.PubMed/NCBI

Al-Sarraf M, Le Blanc M, Giri PG, et al: Superiority of five year survival with chemo-radiotherapy (CT-RT) vs. radiotherapy in patients (Pts) with locally advanced nasopharyngeal cancer (NPC). Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) phase III study: final report. Proc Am Soc Clin Oncol. 20:227a(abstract 905). 2001.

Chan ATC and Felip E: Nasopharyngeal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 20(Suppl 4): 123–125. 2009.

Kam MK, Teo PM, Chau RM, et al: Treatment of nasopharyngeal cancinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 60:1440–1450. 2004. View Article : Google Scholar : PubMed/NCBI

Ngan RK, Yiu HH, Cheng HK, et al: Central nervous system metastasis from nasopharyngeal carcinoma: a report of two patients and a review of the literature. Cancer. 94:398–405. 2002. View Article : Google Scholar : PubMed/NCBI

Baujat B, Audry H, Bourhis J, et al: Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys. 64:47–56. 2006. View Article : Google Scholar

Airoldi M, Gabriele AM, Gazaro M, et al: Induction chemotherapy with cispltin and epirubicin followed by radiotherapy and concurrent cisplatin in locally advanced nasopharyngeal carcinoma observed in a non-endemic population. Radiother Oncol. 92:105–110. 2009. View Article : Google Scholar

Palazzi M, Orlandi E, Bossi P, et al: Futher improvement in outcomes of nasopharyngeal carcinoma with optimized radiotherapy and induction plus concomitant chemotherapy: an update of the Milan experience. Int J Radiat Oncol Biol Phys. 74:774–780. 2009. View Article : Google Scholar

Hui EP, Ma BB, Leung SF, et al: Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma. J Clin Oncol. 27:242–249. 2009. View Article : Google Scholar

Meng ZW, He EH, Meng ZL, et al: Timing changes of apoptosis and proliferating cells nuclear antigen after intra-arteiral infusion chemotherapy for nasopharyngeal carcinoma. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 14:35–37. 2000.(In Chinese).

Hu F, Chen X, Jiang F, et al: Phase II trial of neoadjuvant chemotherapy plus concomitant chemotherapy and intensity modulated radiotherapy with adjuvant chemotherapy for locally advanced nasopharyngeal carcinoma. Zhejiang Med J. 36:836–839. 2010.(In Chinese).